Prince of Wales Hospital is a regional acute government hospital located in Sha Tin, New Territories in Hong Kong. It is also a teaching hospital of the Faculty of Medicine of the Chinese University of Hong Kong.

There are 1,807 beds in Department of Clinical Oncology, Prince of Wales Hospital.

During the past decade, Department of Clinical Oncology, Prince of Wales Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 9 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Clinical Oncology, Prince of Wales Hospital" #1 sponsor was "Chinese University of Hong Kong" with 23 trials, followed by "Hoffmann-La Roche" with 18 trials sponsored, "CCTU" with 4 trials sponsored, "Pfizer" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Clinical Oncology, Prince of Wales Hospital" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator, "Hong Kong Nasopharyngeal Cancer Study Group Limited" with 1 trials as a collaborator, "Prince of Wales Hospital, Shatin, Hong Kong" with 1 trials as a collaborator and "Princess Margaret Hospital, Hong Kong" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Department of Clinical Oncology, Prince of Wales Hospital" are "Breast Cancer" (5 trials), "Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Hepatocellular" (3 trials), "Hepatocellular Carcinoma" (3 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Department of Clinical Oncology, Prince of Wales Hospital" in a lesser frequency.

Most popular intervention types in "Department of Clinical Oncology, Prince of Wales Hospital" are "Drug" (43 trials), "Radiation" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (10 trials), "Cisplatin" (5 trials), "Bevacizumab" (4 trials), "Docetaxel" (4 trials) and "Pemetrexed" (4 trials). Other intervention names were less common.

The vast majority of trials in "Department of Clinical Oncology, Prince of Wales Hospital" are 46 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Department of Clinical Oncology, Prince of Wales Hospital". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Department of Clinical Oncology, Prince of Wales Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Clinical Oncology, Prince of Wales Hospital, 3 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".